Literature DB >> 10458134

Attenuated adenomatous polyposis coli: the role of ascertainment bias through failure to dye-spray at colonoscopy.

M H Wallace1, I M Frayling, S K Clark, K Neale, R K Phillips.   

Abstract

PURPOSE: The aim of this study is to show that the diagnosis of attenuated adenomatous polyposis coli must be made with caution and certainly only after adequate colonic examination with dye-spray.
METHODS: Four patients thought to have attenuated adenomatous polyposis coli on the basis of family history and the identification of fewer than 100 polyps on simple colonoscopy underwent colonoscopy with dye-spray.
RESULTS: All four individuals were found to have more than 100 polyps when dye-spray was used, confirming a diagnosis of classical familial adenomatous polyposis.
CONCLUSIONS: The diagnosis of familial adenomatous polyposis may be missed altogether or incorrectly assigned as attenuated adenomatous polyposis coli if dye-spray is not used at colonoscopy. Patients with a family history of familial adenomatous polyposis or colorectal cancer should be considered for dye-spray before the diagnosis of familial adenomatous polyposis is excluded or one of attenuated adenomatous polyposis coli is made.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10458134     DOI: 10.1007/bf02236707

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  6 in total

1.  Serrated adenomas in FAP. Familial adenomatous polyposis.

Authors:  M C Gallagher; R K S Phillips
Journal:  Gut       Date:  2002-12       Impact factor: 23.059

2.  Barrett esophagus with progression to adenocarcinoma in multiple family members with attenuated familial polyposis.

Authors:  Mayuri Gupta; Deepti Dhavaleshwar; Gupta Vipin; Radheshyam Agrawal
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-05

3.  Variability in the severity of colonic disease in familial adenomatous polyposis results from differences in tumour initiation rather than progression and depends relatively little on patient age.

Authors:  M D Crabtree; I P Tomlinson; I C Talbot; R K Phillips
Journal:  Gut       Date:  2001-10       Impact factor: 23.059

Review 4.  Familial adenomatous polyposis: The practical applications of clinical and molecular screening.

Authors:  Paul Rozen; Finlay Macrae
Journal:  Fam Cancer       Date:  2006       Impact factor: 2.375

5.  [Colorectal polyposis syndrome: a guide to diagnosis].

Authors:  A Roessner; D Kuester; T Guenther
Journal:  Pathologe       Date:  2011-07       Impact factor: 1.011

6.  Guidelines for the management of hereditary colorectal cancer from the British Society of Gastroenterology (BSG)/Association of Coloproctology of Great Britain and Ireland (ACPGBI)/United Kingdom Cancer Genetics Group (UKCGG).

Authors:  Kevin J Monahan; Nicola Bradshaw; Sunil Dolwani; Bianca Desouza; Malcolm G Dunlop; James E East; Mohammad Ilyas; Asha Kaur; Fiona Lalloo; Andrew Latchford; Matthew D Rutter; Ian Tomlinson; Huw J W Thomas; James Hill
Journal:  Gut       Date:  2019-11-28       Impact factor: 23.059

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.